Workflow
飞鹤母乳低聚糖(HMOs)全谱系结构数据库
icon
Search documents
创新引领乳业高质量发展 中国乳制品工业协会第三十一次年会在南京举办
新华网财经· 2025-05-26 09:28
5月23日至25日,中国乳制品工业协会第三十一次年会暨2025年中国乳业技术博览会、2025乳业嘉年华• 全国乳品消费季在南京举办。 本次会议正值中国乳制品工业协会成立三十周年之际,来自国家主管部委领导、南京市人民政府领导、 国内外乳业专家、企业家、企业代表、国际乳品组织及驻华机构代表以及媒体记者齐聚南京,围绕"创 新引领消费 促进全民营养健康"这一主题,共商乳业高质量发展大计。 年会同期举办了"乳业科学家论坛""2025奶酪技术与市场发展论坛""检验检测技术发展论坛""中老年营 养健康创新技术论坛""益生菌和发酵产品发展论坛""携手同行绿色生态发展论坛""特殊医学用途配方食 品发展论坛""乳业标准法规宣贯及发展论坛""特种乳产业发展论坛""乳制品及市场发展论坛""新技术、 新设备、新原料、新产品'四新'发布会"十场专业论坛,百余名专家学者、企业代表分享了最新的研究 成果与实践经验,这些专业论坛不仅为行业内外的专家、学者和企业代表提供了交流的平台,更为中国 乳业的高质量发展提供了智力支持和实践指导。 中国轻工业联合会党委常委、副会长、中国乳制品工业协会理事长刘江毅 行业正面临多重挑战 创新仍是发展关键 "过去 ...
母乳研究国际领先!飞鹤(06186)发布中国首个应用型HMOs数据库 推动行业高质量发展
智通财经网· 2025-05-26 01:58
Core Viewpoint - The China Feihe Dairy has launched the first application-oriented Human Milk Oligosaccharides (HMOs) full-spectrum structural database in China, which aims to enhance research efficiency and quality in the dairy industry [1][4]. Group 1: HMO Database Launch - The HMO database is characterized by its full spectrum, high precision, and strong practicality, addressing significant challenges in HMO detection and identification within the industry [1][2]. - The database enables precise analysis of 233 types of full-spectrum HMOs, significantly improving research speed and efficiency, marking a new era in HMO analysis [2][3]. Group 2: Industry Impact and Collaboration - Feihe's initiative fills a critical gap in HMO detection standards, providing a scientific basis for quality testing and supporting the development of new products in the industry [2][6]. - The database will be shared with the industry to facilitate efficient detection and analysis, promoting innovation and research collaboration among industry professionals [3][6]. Group 3: National Research Project - The HMO database is part of a national key research project under the "14th Five-Year Plan," which aims to enhance the understanding of breast milk and improve infant formula [3][6]. - Feihe has partnered with top universities and research institutions, investing nearly 100 million yuan to achieve significant breakthroughs in maternal and infant health research [6].